Results 161 to 170 of about 26,228 (200)

A BSL-2 chimeric system designed to screen SARS-CoV-2 E protein ion channel inhibitors. [PDF]

J Virol
Negi V, Kuhn RJ.
europepmc   +1 more source

Moving to a non-dopaminergic approach for the treatment of OFF fluctuations in Parkinson's disease. [PDF]

Clin Park Relat Disord
Isaacson SH, Jenner P.
europepmc   +1 more source

Molecular biophysics and inhibition mechanism of influenza virus A M2 viroporin by adamantane-based drugs - Challenges in designing antiviral agents. [PDF]

J Struct Biol X
Georgiou K, Kolokouris D, Kolocouris A.
europepmc   +1 more source

National guidelines for diagnosis and management of Parkinson’s disease in Pakistan [PDF]

, 2015
Ali, Farwa, Awan, Irshad, Barech, Saleem, Basheer, Haroon, Ikram, Amer, Jamil, Sarwar, Lakhair, Manzoor, Numan, Ahsan, Shahbaz, Naila, Sheerani, Mughis, Sher, Khalid, Soomro, Bashir, Syed, Nadir A   +12 more
core   +1 more source

Neurophysiological Treatment Effects of Mesdopetam, Pimavanserin and Amantadine in a Rodent Model of Levodopa-Induced Dyskinesia. [PDF]

Eur J Neurosci
Ronaghi A, Stan TL, Barrientos SA, Halje P, Nasretdinov A, Censoni L, Sato SS, Malinina E, Tedroff J, Waters N, Petersson P.   +10 more
europepmc   +1 more source

Sensitive detection of amantadine in food matrices using DTT-functionalized gold nanoparticles. [PDF]

RSC Adv
Alasiri G, Alaseem AM, Ali ABH, Ali R, El-Wekil MM.   +4 more
europepmc   +1 more source